Mammoth Biosciences
CRISPR Gene Editing & Diagnostics
1 open roleCRISPR Gene Editing & DiagnosticsBrisbane, United States169 employees$375M raisedEst. 2017
8VC
Mayfield
NFX
Decheng Capital
Foresite Capital
Redmile Group
About Mammoth Biosciences
- Mammoth Biosciences is a biotechnology company based in Brisbane, California.
- Founded in 2017, it focuses on discovering novel CRISPR systems for both diagnostic and therapeutic applications, leveraging its proprietary ultracompact CRISPR technology to develop potential long-term curative therapies.
Mammoth Biosciences is listed on Rocketlist with 1 active role. The company is categorized as CRISPR Gene Editing & Diagnostics in BioTech. Mammoth Biosciences is at Series D+ stage, with a B2B business model, headquartered in Brisbane, United States. Mammoth Biosciences was founded in 2017 and has 169 employees. Mammoth Biosciences has raised $375M. Active roles are refreshed daily from public hiring sources.